AU2022289035A1 - Aav vector column purification methods - Google Patents

Aav vector column purification methods Download PDF

Info

Publication number
AU2022289035A1
AU2022289035A1 AU2022289035A AU2022289035A AU2022289035A1 AU 2022289035 A1 AU2022289035 A1 AU 2022289035A1 AU 2022289035 A AU2022289035 A AU 2022289035A AU 2022289035 A AU2022289035 A AU 2022289035A AU 2022289035 A1 AU2022289035 A1 AU 2022289035A1
Authority
AU
Australia
Prior art keywords
full
particles
column
chromatography medium
raav
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022289035A
Other languages
English (en)
Inventor
Mi JIN
Ohnmar KHANAL
Vijesh KUMAR
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Spark Therapeutics Inc
Original Assignee
Spark Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spark Therapeutics Inc filed Critical Spark Therapeutics Inc
Publication of AU2022289035A1 publication Critical patent/AU2022289035A1/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361Ion-exchange
    • B01D15/363Anion-exchange
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/42Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
    • B01D15/422Displacement mode
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14111Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14111Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14151Methods of production or purification of viral material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
AU2022289035A 2021-06-11 2022-06-10 Aav vector column purification methods Pending AU2022289035A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163209680P 2021-06-11 2021-06-11
US63/209,680 2021-06-11
US202263366094P 2022-06-09 2022-06-09
US63/366,094 2022-06-09
PCT/US2022/072859 WO2022261663A1 (en) 2021-06-11 2022-06-10 Aav vector column purification methods

Publications (1)

Publication Number Publication Date
AU2022289035A1 true AU2022289035A1 (en) 2024-01-04

Family

ID=84426294

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2022289035A Pending AU2022289035A1 (en) 2021-06-11 2022-06-10 Aav vector column purification methods

Country Status (13)

Country Link
US (1) US20240271159A1 (https=)
EP (1) EP4351755A4 (https=)
JP (1) JP2024525142A (https=)
KR (1) KR20240021231A (https=)
AU (1) AU2022289035A1 (https=)
BR (1) BR112023025999A2 (https=)
CA (1) CA3221540A1 (https=)
CL (1) CL2023003646A1 (https=)
CO (1) CO2023018191A2 (https=)
IL (1) IL309070A (https=)
MX (1) MX2023014809A (https=)
PE (1) PE20240359A1 (https=)
WO (1) WO2022261663A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024036251A1 (en) * 2022-08-12 2024-02-15 Ultragenyx Pharmaceutical Inc. Novel anion-exchange chromatography methods for separation of empty from full recombinant adeno-associated virus particles
EP4670812A1 (en) * 2024-06-27 2025-12-31 Sartorius Stedim Biotech GmbH CONTINUOUS POLISHING OF VIRAL CAPSIDES
WO2026064763A1 (en) * 2024-09-23 2026-03-26 Regeneron Pharmaceuticals, Inc. Partitioning anion exchange chromatography for purification of recombinant adeno-associated virus (raav)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004030327D1 (de) * 2003-05-21 2011-01-13 Genzyme Corp Verfahren zur herstellung von präparationen rekombinanter aav-virionen, die weitgehend frei von leeren capsiden sind
US20120093775A1 (en) * 2009-03-27 2012-04-19 Proyecto De Biomedicina Cima, S.L. Methods and compositions for the treatment of cirrhosis and liver fibrosis
MY207534A (en) * 2017-06-30 2025-03-03 Spark Therapeutics Inc Aav vector column purification methods
US20230183659A1 (en) * 2021-10-29 2023-06-15 Homology Medicines, Inc. Methods and compositions for the purification of adeno-associated virus
EP4602172A1 (en) * 2022-10-11 2025-08-20 MeiraGTx UK II Limited Chromatography methods for purification of aav capsids

Also Published As

Publication number Publication date
JP2024525142A (ja) 2024-07-10
IL309070A (en) 2024-02-01
US20240271159A1 (en) 2024-08-15
CO2023018191A2 (es) 2024-01-25
WO2022261663A1 (en) 2022-12-15
EP4351755A4 (en) 2025-04-23
EP4351755A1 (en) 2024-04-17
BR112023025999A2 (pt) 2024-02-27
PE20240359A1 (es) 2024-02-27
KR20240021231A (ko) 2024-02-16
CL2023003646A1 (es) 2024-10-25
CA3221540A1 (en) 2022-12-15
MX2023014809A (es) 2024-01-29

Similar Documents

Publication Publication Date Title
JP7659523B2 (ja) カラムに基づく高度にスケーラブルなrAAVの製造プロセス
KR102669561B1 (ko) Aav 벡터 컬럼 정제 방법
KR102479894B1 (ko) 재조합 단백질 및/또는 바이러스 벡터 생산용 세포주
US20240271159A1 (en) Aav vector column purification methods
JP2025535118A (ja) Aavカプシドの精製のためのクロマトグラフィー方法
CN117794629A (zh) Aav载体的柱纯化方法
WO2025217029A1 (en) Compositions & methods for adeno-associated virus capsid variant purification
RU2772876C2 (ru) Колоночные способы очистки вектора на основе aav
HK40003857B (en) Column-based fully scalable raav manufacturing process
BR112019028299B1 (pt) Método para a purificação de partículas de vetores adenoassociados recombinantes (raav)